Indeed, it was recently reported that SK2 activity promoted cell migration and invasion in pancreatic cancer cells by enhancing an integrin–EGFR–AKT (Protein kinase B) pathway [22, 43]. The gene discussed is EGFR; the disease is pancreatic neoplasm.